SEARCH

SEARCH BY CITATION

References

  • BOYER, J.L., DOWNES, C.P. & HARDEN, T.K. (1989). Kinetics of activation of phospholipase C by P2 purinergic receptor agonists and guanine nucleotides. J. Biol. Chem., 264, 884890.
  • BOYER, J.L., MOHANRAM, A., CAMAIONI, E., JACOBSON, K.A. & HARDEN, T.K. (1998). Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br. J. Pharmacol., 124, 13.
  • BOYER, J.L., O'TUEL, J.W., FISCHER, B., JACOBSON, K.A. & HARDEN, T.K. (1995). Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors. Br. J. Pharmacol., 116, 26112616.
  • BOYER, J.L., ROMERO, T., SCHACHTER, J.B. & HARDEN, T.K. (1996a). Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol., 50, 13231329.
  • BOYER, J.L., SCHACHTER, J.B., SROMEK, S.M., PALMER, R.K., JACOBSON, K.A., NICHOLAS, R.A. & HARDEN, T.K. (1996b). Avian and human homologues of the P2Y1 receptor: pharmacological, signaling, and molecular properties. Drug Dev. Res., 39, 253261.
  • BOYER, J.L., SIDDIQI, S.M., FISCHER, B., JACOBSON, K.A. & HARDEN, T.K. (1996c). Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5′-monophosphate. Br. J. Pharmacol., 118, 19591964.
  • BROWN, S.G., KING, B.F., KIM, Y.-C., BURNSTOCK, G. & JACOBSON, K.A. (2000). Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev. Res., 49, 253259.
  • CAMAIONI, E., BOYER, J.L., MOHANRAM, A., HARDEN, T.K. & JACOBSON, K.A. (1998). Deoxyadenosine-bisphosphate derivatives as potent antagonists at P2Y1 receptors. J. Med. Chem., 41, 183190.
  • DUBYAK, G.R. & EL-MOATASSIM, C. (1993). Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577C606.
  • FABRE, J.E., NGUYEN, M., LATOUR, A., KEIFER, J.A., AUDOLY, L.P., COFFMAN, T.M. & KOLLER, B.H. (1999). Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat. Med., 5, 11991202.
  • FAGURA, M.S., DAINTY, I.A., MCKAY, G.D., KIRK, I.P., HUMPHRIES, R.G., ROBERTSON, M.J., DOUGALL, I.G. & LEFF, P. (1998). P2Y1-receptors in human platelets which are pharmacologically distinct from P2YAOP-receptors. Br. J. Pharmacol., 124, 157164.
  • FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DUBYAK, G.R., HARDEN, T.K., JACOBSON, K.A., SCHWABE, U. & WILLIAMS, M. (1997). Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci., 18, 7982.
  • HARDEN, T.K., BOYER, J.L. & NICHOLAS, R.A. (1995). P2-purinergic receptors: subtype-associated signaling responses and structure. Annu. Rev. Pharmacol. Toxicol., 35, 541579.
  • HARDEN, T.K., BARNARD, E.A., BOEYNAEMS, J.M., BURNSTOCK, G., DUBYAK, G.R., HOURANI, S.M.O. & INSEL, P.A. (1998). P2Y receptors. In The IUPHAR compendium of receptor characterization and classification ed GirdlestoneD pp. 209217, London: IUPHAR Media.
  • HARDEN, T.K., LAZAROWSKI, E.R. & BOUCHER, R.C. (1997). Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol. Sci., 18, 4346.
  • HARDEN, T.K., STEPHENS, L., HAWKINS, P.T. & DOWNES, C.P. (1987). Turkey erythrocyte membranes as a model for regulation of phospholipase C by guanine nucleotides. J. Biol. Chem., 262, 90579061.
  • HECHLER, B., LEON, C., VIAL, C., VIGNE, P., FRELIN, C., CAZENAVE, J.P. & GACHET, C. (1998). The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood, 92, 152159.
  • HOLLOPETER, G., JANTZEN, H.M., VINCENT, D., LI, G., ENGLAND, L., RAMAKRISHNAN, V., YANG, R.B., NURDEN, P., NURDEN, A., JULIUS, D. & CONLEY, P. (2001). Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature, 409, 202207.
  • JIN, J., DANIEL, J.L. & KUNAPULI, S.P. (1998). Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem., 273, 20302034.
  • KIM, Y.-C., GALLO-RODRIGUEZ, C., JANG, S.-Y., NANDANAN, E., ADAMS, M., HARDEN, T.K., BOYER, J.L. & JACOBSON, K.A. (2000). Acyclic analogues of deoxyadenosine 3′,5′-bisphosphates as P2Y1 receptor antagonists. J. Med. Chem., 42, 746755.
  • KIM, H.S., BARAK, D., HARDEN, T.K., BOYER, J.L. & JACOBSON, K.A. (2001). Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: Structure activity relationships and receptor docking. J. Med. Chem., 44, 30923108.
  • KUNAPULI, S.P. (1998). Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Trends Pharmacol. Sci., 19, 391394.
  • LEON, C., HECHLER, B., FREUND, M., ECKLY, A., VIAL, C., OHLMANN, P., DIERICH, A., LEMEUR, M., CAZENAVE, J.P. & GACHET, C. (1999). Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest., 104, 17311737.
  • LEON, C., HECHLER, B., VIAL, C., LERAY, C., CAZENAVE, J.-P. & GACHET, C. (1997). The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS. Lett., 403, 2630.
  • MEEKER, R.B. & HARDEN, T.K. (1982). Muscarinic receptor-mediated activation of phosphodiesterase. Mol. Pharmacol., 22, 310319.
  • NANDANAN, E., JANG, S.Y., MORO, S., KIM, H.O., SIDDIQUI, M.A., RUSS, P., MARQUEZ, V.E., BUSSON, R., HERDEWIJN, P., HARDEN, T.K., BOYER, J.L. & JACOBSON, K.A. (2000). Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y1 receptor ligands. J. Med. Chem., 43, 829842.
  • RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413492.
  • SAVI, P., BEAUVERGER, P., LABOURET, C., DELFAUD, M., SALEL, V., KAGHAD, M. & HERBERT, J.M. (1998). Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett., 422, 291295.
  • SCHACHTER, J.B., LI, Q., BOYER, J.L., NICHOLAS, R.A. & HARDEN, T.K. (1996). Second messenger cascade specificity and pharmacological selectivity of the human P2Y1 receptor. Br. J. Pharmacol., 118, 167173.
  • WEBB, T.E. & BARNARD, E.A. (1999). Molecular biology of P2Y receptors expressed in the nervous system. Prog. Brain Res., 120, 2331.
  • ZIMMERMANN, H. (1996). Extracellular purine metabolism. Drug Dev. Res., 39, 337352.